EWTX - CIK 0001710072
Edgewise Therapeutics, Inc. has filed 384 documents with the SEC between 2019 and 2026. The most frequent type is insider trade (158 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Quarterly report | 10-Q | 2024-05-09 | 2024-03-31 |
| Employee stock plan | S-8 | 2024-05-09 | - |
| Major company event | 8-K | 2024-05-09 | 2024-05-09 |
| Insider trade | 4 | 2024-05-07 | 2024-05-06 |
| New insider ownership | 3 | 2024-05-07 | 2024-05-06 |
| Proxy materials | DEFA14A | 2024-05-07 | - |
| Major company event | 8-K | 2024-05-07 | 2024-05-06 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Insider trade | 4 | 2024-05-03 | 2024-05-01 |
| Proxy materials | DEFA14A | 2024-04-26 | - |
| Proxy statement | DEF 14A | 2024-04-26 | 2024-06-07 |
| PRE 14A | - | 2024-04-15 | 2024-06-07 |
| Annual report | 10-K | 2024-02-22 | 2023-12-31 |
| Major company event | 8-K | 2024-02-22 | 2024-02-22 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Insider trade | 4 | 2024-02-09 | 2024-02-07 |
| Insider trade | 4 | 2024-02-09 | 2024-02-07 |
| Passive ownership stake (update) | SC 13G/A | 2024-02-09 | - |
| Insider sale notice | 144 | 2024-02-07 | - |
| Insider sale notice | 144 | 2024-02-07 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-01 | - |
| Passive ownership stake | SC 13G | 2024-01-29 | - |
| Insider trade | 4 | 2024-01-25 | 2024-01-23 |
| Activist ownership stake (update) | SC 13D/A | 2024-01-25 | - |
| Insider trade | 4 | 2024-01-25 | 2024-01-23 |
| Insider trade | 4 | 2024-01-25 | 2024-01-23 |
| Activist ownership stake (update) | SC 13D/A | 2024-01-25 | - |
| Insider sale notice | 144 | 2024-01-23 | - |
| Prospectus supplement | 424B5 | 2024-01-19 | - |
| Major company event | 8-K | 2024-01-19 | 2024-01-19 |
| Major company event | 8-K | 2024-01-19 | 2024-01-19 |
| S-3MEF | - | 2024-01-19 | - |
| 424B3 | - | 2024-01-19 | - |
| Insider trade | 4 | 2023-12-28 | 2023-12-26 |
| Insider trade | 4 | 2023-12-28 | 2023-12-27 |
| Insider trade | 4 | 2023-12-28 | 2023-12-26 |
| Insider sale notice | 144 | 2023-12-27 | - |
| Insider sale notice | 144 | 2023-12-26 | - |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Insider trade | 4 | 2023-08-18 | 2023-08-17 |
| Insider trade | 4 | 2023-08-18 | 2023-08-17 |
| Insider trade | 4 | 2023-08-18 | 2023-08-17 |
| Insider trade | 4 | 2023-08-18 | 2023-08-17 |
| Insider trade | 4 | 2023-08-18 | 2023-08-17 |